Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Robot-assisted surgery to control prostate cancer effective in controlling disease for 10 years

Robot-assisted surgery to remove cancerous prostate glands is effective in controlling the disease for 10 years, according to a new study led by researchers at Henry Ford Hospital.

17 Jul 2014

Game theory identifies ideal time to disrupt metastatic cancer cell cooperation

Cancer's no game, but researchers at Johns Hopkins are borrowing ideas from evolutionary game theory to learn how cells cooperate within a tumor to gather energy.

16 Jul 2014

Prostate cancer more likely to be aggressive in younger men

The number of younger men diagnosed with prostate cancer has increased nearly 6-fold in the last 20 years, and the disease is more likely to be aggressive in these younger men, according to a new analysis from researchers at the University of Michigan Comprehensive Cancer Center.

16 Jul 2014

Johnson & Johnson sales increase 9.1% to $19.5 billion in second quarter 2014

Johnson & Johnson today announced sales of $19.5 billion for the second quarter of 2014, an increase of 9.1% as compared to the second quarter of 2013. Operational results increased 9.4% and the negative impact of currency was 0.3%.

15 Jul 2014

New research explores why active surveillance underused in patients with prostate cancer

New research from The University of Texas MD Anderson Cancer Center is shedding light on the important role a diagnosing urologist plays in whether older men with low-risk prostate cancer receive treatment for their disease, and if so, the type of treatment they receive as a result.

15 Jul 2014

Researchers identify new suppressor of cancer metastasis

Among patients with deadly cancers, more than 90 percent die because of metastatic spread of their disease. Looking to target a key pathway in order to interfere with the processes that lead to tumor spread, a research team led by Irwin H. Gelman, Ph.D., of Roswell Park Cancer Institute (RPCI) has identified a new suppressor of cancer metastasis that may point the way toward development of more effective treatments for prostate cancers and other malignant solid tumors.

14 Jul 2014

New online medical professional video center from Mayo Clinic

Mayo Clinic is now making its video education medical grand rounds lectures and clinical presentations on recent innovations in patient care, education and research accessible to other medical professionals in the new online medical professional video center.

11 Jul 2014

Vasectomy associated with small increased risk of prostate cancer

Vasectomy was associated with a small increased risk of prostate cancer, and a stronger risk for advanced or lethal prostate cancer according to a new study from Harvard School of Public Health.

10 Jul 2014

Sheffield Hallam University launches online course in Enhancing Prostate Cancer Care

Sheffield Hallam University has joined the fight against one of the UK's biggest cancer killers by launching its first Massive Open Online Course (MOOC) in Enhancing Prostate Cancer Care.

9 Jul 2014

Penrose Senior Care Auditors, The Caregiver Partnership join forces to improve lives of aging seniors

Penrose Senior Care Auditors, the only national company that checks on seniors and their living conditions, and reports back to their loved-ones, is pleased to announce a partnership with The Caregiver Partnership, a leading online resource for home health care products, services and family caregiving information.

9 Jul 2014

Genetic variants linked with greater risk for radiation-driven side effects in cancer patients

Key genetic variants may affect how cancer patients respond to radiation treatments, according to a study published this week in Nature Genetics.

8 Jul 2014

Study examines whether men who ride have higher risk of erectile dysfunction, infertility, prostate cancer

Cycling is a popular activity that offers clear health benefits, but there is an ongoing controversy about whether men who ride have a higher risk of urogenital disorders such as erectile dysfunction, infertility, or prostate cancer.

8 Jul 2014

Loss of p62 protein in cells and tissue surrounding a tumor can influence tumor growth

A team of scientists from Sanford Burnham Medical Research Institute has found that the loss of a protein called p62 in the cells and tissue surrounding a tumor can enhance the growth and progression of tumors.

4 Jul 2014

Study explores how surgical innovation can lead to adverse events for patients

Researchers at the University of California, San Diego School of Medicine have found that the risk of patient harm increased two-fold in 2006 - the peak year that teaching hospitals nationwide embraced the pursuit of minimally invasive robotic surgery for prostate cancer. Results of the study are published in the July 2 online issue of JAMA Surgery.

3 Jul 2014

HIV-positive people with early-stage cancer less likely to get cancer treatment

HIV-infected people diagnosed with cancer are two to four times more likely to go untreated for their cancer compared to uninfected cancer patients, according to a new, large retrospective study from researchers in Penn Medicine's Abramson Cancer Center and the National Cancer Institute (NCI) published online ahead of print in the Journal of Clinical Oncology.

1 Jul 2014

MagForce publishes operative highlights and financial results for fiscal year 2013

MagForce AG, a leading medical device company in the field of nanomedicine focused on oncology, published today its financial results for the fiscal year ending on December 31, 2013 and operative highlights.

30 Jun 2014

Chesapeake Urology presents $114,248 to Urology Care Foundation for prostate cancer research

In ongoing support of prostate cancer research, Sanford Siegel, M.D., President and CEO of Chesapeake Urology Associates, presented the Urology Care Foundation with a check for $114,248 in support of its prostate cancer research efforts.

28 Jun 2014

Janssen seeks expanded approval of VELCADE from EU for Mantle Cell Lymphoma

Janssen-Cilag International NV today announced its submission of a type II variation to the European Medicines Agency to expand the label for VELCADE (bortezomib) to include its use, in combination with rituximab, cyclophosphamide, doxorubicin and prednisone, for the treatment of adult patients with previously untreated Mantle Cell Lymphoma (MCL).

28 Jun 2014

Study identifies genetics as dominant risk factor in breast, prostate and colorectal cancers

A study of individuals who have been adopted has identified genetics as the dominant risk factor in 'familial' breast, prostate and colorectal cancers.

27 Jun 2014

New technology could revolutionize treatment and prevention of sepsis

The National Science Foundation has just awarded $200,000 to engineers at Oregon State University who have developed a new technology that they believe could revolutionize the treatment and prevention of sepsis.

27 Jun 2014

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Robot-assisted surgery to control prostate cancer effective in controlling disease for 10 years

Game theory identifies ideal time to disrupt metastatic cancer cell cooperation

Prostate cancer more likely to be aggressive in younger men

Johnson & Johnson sales increase 9.1% to $19.5 billion in second quarter 2014

New research explores why active surveillance underused in patients with prostate cancer

Researchers identify new suppressor of cancer metastasis

New online medical professional video center from Mayo Clinic

Vasectomy associated with small increased risk of prostate cancer

Sheffield Hallam University launches online course in Enhancing Prostate Cancer Care

Penrose Senior Care Auditors, The Caregiver Partnership join forces to improve lives of aging seniors

Genetic variants linked with greater risk for radiation-driven side effects in cancer patients

Study examines whether men who ride have higher risk of erectile dysfunction, infertility, prostate cancer

Loss of p62 protein in cells and tissue surrounding a tumor can influence tumor growth

Study explores how surgical innovation can lead to adverse events for patients

HIV-positive people with early-stage cancer less likely to get cancer treatment

MagForce publishes operative highlights and financial results for fiscal year 2013

Chesapeake Urology presents $114,248 to Urology Care Foundation for prostate cancer research

Janssen seeks expanded approval of VELCADE from EU for Mantle Cell Lymphoma

Study identifies genetics as dominant risk factor in breast, prostate and colorectal cancers

New technology could revolutionize treatment and prevention of sepsis

What to know about prostate cancer eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in